https://www.selleckchem.com/products/mira-1.html
To evaluate the possible synergic effect of cisplatin and low molecular weight heparin (LMWH) on oral squamous cell carcinoma (OSCC). Cisplatin and enoxaparin sodium, alone or in combination, were administered at doses of 1, 2, 4, 8 and 10 µM and 0.1, 0.5, 1, 5, 10, 50, and 100 µg/ml, respectively, to the H357 human OSCC line. The effects on cell viability and apoptosis were evaluated after 24, 48, and 72h and on cell migration after 18 and 24h. 10 µM concentration of cisplatin produced the greatest decrease in cell viability, with signi
Like
Comment
Share
